EDITORIALThe original biological aortic valve replacement was, of course, the homograft introduced in 1962. 1 These valves were all inserted in a subcoronary position and it took some years and painstaking appraisal before they could be inserted with a satisfactory degree of competence. In other words, there was an early learning curve but the lessons learnt are still applicable today.Among other considerations, the initial sizing of the homograft is of importance and it should be remembered that the given size of a homograft means the internal diameter. If to this we add the thickness of the wall, then the effective external diameter of the implant will be 2 to 3 mm larger. This fact should be kept in mind. Also, a double-layer suture insertion is commonly used together with interrupted sutures at the lower margin and a continuous suture along the upper margin, ensuring that the commissures are elevated under some tension to prevent subsequent cusp prolapse. Finally, the noncoronary sinus is kept intact to maintain the spatial relationships between the adjacent commissures, which is an important feature in achieving competence. With these guidelines, it is certainly possible to achieve a competent subcoronary valve placement, whether it is a homograft, autograft, or xenograft but, because of the initial learning curve, many surgeons wishing to use a biological valve opted for the less satisfactory and bulky stented variety. 2 The first free-standing aortic root was used in 1972 in a case of aortic root abscess, in which there was aorto-left ventricular discontinuity. 3 The pus was evacuated, the ventricle and aorta were re-anastomosed to a homograft root and the coronaries were reimplanted. While there were still early learning problems and difficulties in inserting a subcoronary replacement, the concept of using a free-standing root replacement was increasingly appealing, since it almost guarantees a competent valve. 4 This applies even in relatively inexperienced hands and, not surprisingly, the technique is used almost exclusively in the autograft operation.Scanning the surgical journals over the years, it has been fascinating to read what is supposed to constitute a longterm valve follow-up: sometimes it is 3 years, sometimes 5, and others talk of long-term follow-up with two or three patients available for assessment at about 7 to 8 years in the case of many of the so-called stentless valves. The thing we have learned from our considerable experience with over 2,000 homograft valves, is that 7 years is the watershed which determines whether the valve will continue to function satisfactorily ("7-year itch"). Up to that point, all valves are excellent, so to make a reasonable assessment one needs a satisfactory cohort of patients at least 10 years and preferably 20 years post-implantation.Homograft valves are collected from cadavers under 45 years of age, (preferably, nearer 20 years) and processed within 24 hours of death when the body has been kept in a morgue refrigerator. They are then either stored for ...